Alexandru Calin Grigorescu (2025) “Tirosine Kinase Inhibitors (TKI) Used in the Treatment of Non-Small Cell Lung Cancer (NSCLC) Based on Specific Genetic Alterations”, Medical Science: Trends and Innovations Vol. 4, pp. 86–93. doi: 10.9734/bpi/msti/v4/4098.